Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11376 - 11400 of 12766 in total
Experimental
Matched Iupac: … (2-aminoethoxy)[(2R)-2-[(9E,12E)-hexadeca-9,12-dienoyloxy]-3-[(8E,16E)-octadeca-8,12,16-trienoyloxy]propoxy …
Experimental
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(naphthalen-1-yl)methyl]sulfanyl}ethyl]carbamoyl …
Experimental
Matched Iupac: … (2S)-2-amino-3-({hydroxy[(2R)-2-hydroxy-3-{[(1R)-1-hydroxypentadecyl]oxy}propoxy]phosphoryl}oxy)propanoic …
Decoglurant has been used in trials studying the treatment of Major Depressive Disorder.
Investigational
Matched Iupac: … 5-{2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl}pyridin- ... 2-amine …
Sch 486757 has been used in trials studying the treatment of Cough.
Investigational
Matched Iupac: … (1R,3R,5S)-8-[bis(2-chlorophenyl)methyl]-3-(pyrimidin-2-yl)-8-azabicyclo[3.2.1]octan-3-ol …
Atabecestat is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates).
Investigational
Matched Iupac: … N-{3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide …
Investigational
Matched Iupac: … (2S)-N-[(1S)-1-{[(2S)-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl}-3-methylbutyl]-2-acetamido-4-methylpentanamide …
Investigational
Matched Iupac: … 2-fluoro-5-methoxy-4-({4-[(2-methyl-3-oxo-2,3-dihydro-1H-isoindol-4-yl)oxy]-5-(trifluoromethyl)pyrimidin ... -2-yl}amino)-N-(1-methylpiperidin-4-yl)benzamide …
Experimental
Matched Iupac: … 2-(naphthalen-1-yl)acetic acid …
Experimental
Matched Iupac: … (2R)-2-(carbamoylamino)-3-methylbutanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-selenonylpropanoic acid …
An essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine), and thyroxine. [PubChem]
Experimental
Matched Iupac: … (2R)-2-amino-3-phenylpropanoic acid …
Experimental
Matched Iupac: … N-[(2S)-heptan-2-yl]formamide …
Experimental
Matched Iupac: … (2S)-2-amino-5-ethanimidamidopentanoic acid …
Experimental
Matched Iupac: … (2-formyl-6-methoxyphenoxy)phosphonic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-(propyldisulfanyl)propanal …
Experimental
Matched Iupac: … 2-(4-fluorophenyl)ethan-1-ol …
Experimental
Matched Iupac: … (2S)-2-amino-3,3,3-trifluoropropanoic acid …
A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
Experimental
Matched Iupac: … (2R)-2-amino-3-carbamoylpropanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-6-carbamimidamidohexanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-4-oxobutanoic acid …
Experimental
Matched Iupac: … (2S)-2-hexanamido-4-sulfanylbutanoic acid …
N-(carboxycarbonyl)-D-phenylalanine is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. It targets the protein hypoxia-inducible factor 1-alpha inhibitor.
Experimental
Matched Iupac: … (2R)-2-(carboxyformamido)-3-phenylpropanoic acid …
COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory Degenerative Joint Disease. COP has been investigated for the treatment of Diabetic Retinopathy.
Investigational
Matched Iupac: … [2-(N-methylcarbamimidamido)ethoxy]phosphonic acid …
Experimental
Matched Iupac: … N-(2-oxothiolan-3-yl)acetamide …
Displaying drugs 11376 - 11400 of 12766 in total